Lear (LEA) CEO Sells 5,000 Shares at ~$97 – Form 4 Insight
Form 4 filing for Lear Corp. (LEA) discloses that President & CEO Raymond E. Scott, who is also a director, sold a total of 5,000 common shares on 29 Jul 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Form 4 filing for Lear Corp. (LEA) discloses that President & CEO Raymond E. Scott, who is also a director, sold a total of 5,000 common shares on 29 Jul 2025.
- Weighted‐average sale prices: $96.5789 for 4,354 shares, $97.8828 for 504 shares, and $98.8444 for 142 shares (detailed price ranges provided).
- Gross proceeds ≈ $485 k.
- Following the transactions, Scott directly owns 38,729 shares, down roughly 11% from 43,729.
No derivative transactions were reported. The filing was signed by attorney-in-fact Jacqlyn Waite on 31 Jul 2025.
While the sale is modest relative to Lear’s market capitalization and Scott retains a sizable stake, investors often monitor CEO sales for potential sentiment signals.
Positive
- None.
Negative
- CEO insider selling: 5,000-share sale (~11 % of direct stake) can be interpreted as a mildly negative sentiment signal.
Insights
TL;DR: CEO sold 5k shares (~11% of holdings); signal is mildly negative but not necessarily material.
The transaction equals ≈ $0.5 m, minor versus Lear’s daily trading volume and Scott’s remaining 38.7 k shares. No accompanying news or 10b5-1 indication is provided, so motive is unclear. Historically, insider sales of <20 % holdings are not strongly predictive of price moves, yet markets sometimes treat CEO disposals as cautionary. I view impact as limited unless followed by additional sales.
TL;DR: Routine insider sale; ownership drop immaterial to control; governance impact negligible.
Scott remains both CEO and director with a direct stake above typical guideline thresholds for alignment. No derivatives or unusual structures appear. Filing timeliness and price range disclosure comply with Rule 16a-3. Unless selling accelerates or coincides with negative events, governance risk remains low.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 4,354 | $96.5789 | $421K |
| Sale | Common Stock | 504 | $97.8828 | $49K |
| Sale | Common Stock | 142 | $98.8444 | $14K |
Footnotes (3)
- F1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.286 to $97.23, inclusive. The reporting person undertakes to provide the registrant, any security holder of the registrant, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above.
- F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.331 to $98.316, inclusive. The reporting person undertakes to provide the registrant, any security holder of the registrant, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above.
- F3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.345 to $99.008, inclusive. The reporting person undertakes to provide the registrant, any security holder of the registrant, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Does the Form 4 mention any derivative transactions?
Is this sale part of a Rule 10b5-1 trading plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.